SPONSOR
Yunfeng Cheng
Total Trials
3
Recruiting
3
Phases
N/A
Conditions studied: Immune Thrombocytopenia With Positive ANA Antibodies
Yunfeng Cheng is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Immune Thrombocytopenia With Positive ANA Antibodies.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Yunfeng Cheng
How many clinical trials has Yunfeng Cheng sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Yunfeng Cheng, of which 3 are actively recruiting participants. These trials cover conditions including Immune Thrombocytopenia With Positive ANA Antibodies. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Yunfeng Cheng research focus on?
Yunfeng Cheng clinical trials span Immune Thrombocytopenia With Positive ANA Antibodies. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Yunfeng Cheng clinical trial?
To participate in a Yunfeng Cheng trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Yunfeng Cheng trials with current recruitment status updated daily.
Clinical Trials by Yunfeng Cheng
NCT06479317
Recruiting
The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP
Immune Thrombocytopenia With Positive ANA Antibodies
NCT06479304
Recruiting
The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP
Immune Thrombocytopenia With Positive ANA Antibodies
NCT06479291
Recruiting
The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP
Immune Thrombocytopenia With Positive ANA Antibodies
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology